Keywords
How to Cite
Abstract
The objective of this study was to assess the adherence to self-monitoring of blood glucose and the main factors associated with it, in patients with type 2 diabetes in Algeria. This was a descriptive, cross-sectional epidemiological study of type 2 diabetic patients in the Tiaret region (western Algeria). Socio-demographic, clinical and therapeutic data were collected using a questionnaire. The conditions under which self-monitoring of blood glucose was carried out were determined by considering the criteria of the good practice guidelines established by the Francophone Diabetes Society. A multivariate analysis by logistic regression was performed to identify the predictive factors.
The study included 419 type 2 diabetic patients followed up, on an outpatient basis in public and private facilities in the Tiaret region (western Algeria). Among them, 58% were not adherent to SMBG. Several predictive factors were associated with poor adherence to SMBG, such as poor glycaemic control, use of oral antidiabetic drugs combined with insulin, age, duration of the
disease and forgetting to take the medication. However, other factors favoured the good adherence, such as whether the patient was active, married, urban, had hypo- or hyperglycaemia in the previous three months, as well as patients with dyslipidaemia. Patients whose capillary blood glucose was measured by a relative were also more adherent.
According to our results, it is necessary to implement an action plan to address the poor adherence to SMBG, which is a frequent and multifactorial phenomenon in Algeria. Therapeutic education must be an integral part of the management of the type 2 diabetic patient. It helps patients and their families to better understand the disease, the treatments and to improve their quality of life.
References
FID. Atlas du diabète de la FID, 8ème édition. Fédération Internationale du Diabète. 2019
Institut National de Santé Publique. Projet TAHINA (Transition épidémiologique et impact sur la santé en Afrique du Nord), enquête nationale de santé 2005 (Contrat N° ICA3-CT-2002-10011). Algiers; 2005
Zaoui S, Biémont C, Meguenni K. Approche épidémiologique du diabète en milieux urbain et rural dans la région de Tlemcen (Ouest algérien). Cahiers d'études et de recherches francophones / Santé. 2007;17(1):15-21.
Houti L, Hamani-Medjaoui I, Lardjam, Hetraf SA, Ouhaibi-Djellouli H, Chougrani S, Goumidi L, Mediene Benchekor S. Prevalence of Metabolic Syndrome and its Related Risk Factors in the City of Oran, Algeria: the ISOR Study. EthnDis. 2016 Jan 21;26(1):99-106.
Ministre de la santé, de la population et de la réforme hospitalière. Enquête nationale sur la mesure du poids et facteurs de risque des maladies non transmissibles selon l'approche STEPwise de l'OMS.Principaux résultats.Algiers; 2017.
Ficher-Ghanassia, P., Ghanassia, E., Bringer, J, ed. Le diabéte, Endocrinologie-Nutrition 6ème édition. Paris ; 2012.
Mosnier-Pudar, H. Autosurveillance glycémique: pour qui, comment, et pourquoi? Le généraliste; 2012 ; 2613(1).
Haute autorité de santé. Bon usage des technologies de santé, L'autosurveillance glycémique dans le diabète de type 2 : une utilisation très ciblée. Paris ; 2011.
Reach, G. L’observance à la pratique de l’auto-surveillance. Médecine des maladies Métaboliques. 2010 ; 4, S36S40.
Hansen MV, Pedersen-Bjergaard U, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Pramming S,
Thorsteinsson B. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract. 2009 Aug;85(2):183-8.
Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self-monitoring of blood glucose: language and financial barriers in amanaged care population with diabetes. Diabetes Care. 2000 Apr;23(4):477-83.
Achouri, MY, Selka MA, Belhadj A, Karasse A, Lazzaz MA,Talha B. et al. Utilisation des lecteurs d'autosurveillance glycémqiue : enquête auprès des diabétiques de la région de Sidi BelAbbès (Algérie). Algerian Journal of Pharmacy. 2019 ; 2(1): 49–53.
Achouri MY, Mammeri M, Sehanine Y, Selka MA, Ghomari WI, Lahmer A, Hadj Habib M. Facteurs associés à la nonobservance thérapeutique chez les diabétiques de type 2 : première enquête algérienne. Ann Pharm Fr. 2019(6):506-515.
Société Francophone du Diabète Paramédical.Surveillance glycémique et technique d’injection d’insuline et des anlogues du GLP1.Paris; 2017
Wang X, Luo JF, Qi L, Long Q, Guo J, Wang HH.Adherence to self-monitoring of blood glucose in Chinese patients with type 2 diabetes: current status and influential factors based on electronic questionnaires. Patient Prefer Adherence. 2019 Jul 25;13:1269-1282.
Yuan L, Guo X, Xiong Z, Lou Q, Shen L, Zhao F, Sun Z, Li J. Self-monitoring of blood glucose in type 2 diabetic patients in China: current status and influential factors. Chin Med J (Engl). 2014;127(2):201-7.
Hu ZD, Zhang KP, Huang Y, Zhu S. Compliance to self-monitoring of blood glucose among patients with type 2 diabetes mellitus and its influential factors: a real-world cross-sectional study based on the Tencent TDF-I blood glucose monitoring platform. Mhealth. 2017 Jun 27;3:25.
Wambui Charity K, Kumar AMV, Hinderaker SG, Chinnakali P, Pastakia SD, Kamano J. Do diabetes mellitus patients adhere to self- monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya. Diabetes Res Clin Pract. 2016 Feb;112:37-43.
Al-Keilani MS, Almomani BA, AlSawalha NA, Shhabat BA. Self-monitoring of blood glucose among patients with diabetes in Jordan: Perception, adherence, and influential factors. Diabetes Res Clin Pract. 2017 Apr;126:79-85.
Cano-Blanquer D, Cervera-Casino P, Peiró-Moreno S, Mateu-García M, Barreda-Aznar A; Grupo de Estudio de la Automonitorización Glucémica. Prevalence and associated factors in selfmonitoring of blood glucose in non insulin-treated type 2 diabetes patients in the Valencia Community, Spain. Rev Esp Salud Publica. 2013 Mar- Apr;87(2):149-63.
Vidal Flor M, Jansà Morató M, Galindo Rubio M, Penalba Martínez M. Factors associated to adherence to blood glucose self-monitoring in patients with diabetes treated with insulin. The dapa study. Endocrinol Diabetes Nutr(Engl Ed). 2018 Feb;65(2):99-106.
Adams AS, Mah C, Soumerai SB, Zhang F, Barton MB, Ross-Degnan D. Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study. BMC Health Serv Res. 2003 Mar 19;3(1):6.
Hjelm K, Per N, Jan A. Self-Monitoring of Blood Glucose; Frequency, Determinants and Self-Adjustment of Treatment in an Adult Swedish Diabetic Populatin: Utilisation and Determinants of SMBG. Practical Diabetes International. 2001; 18(5): 157–63.
Scorpiglione N, el-Shazly M, AbdelFattah M, Belfiglio M, Cavaliere D, Carinci F, Labbrozzi D, Mari E, Massi Benedetti M, Tognoni G, Nicolucci A. Epidemiology and determinants of blood glucose self-monitoring in clinical practice. Diabetes Res Clin Pract. 1996 Oct;34(2):115-25.
Harris MI, Cowie CC, Howie LJ. Selfmonitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care. 1993 Aug;16(8):1116-23.
Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group: Self- monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587–594
Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA:Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49:271–278
Garg SK, Hirsch IB. Self-Monitoring of Blood Glucose. Diabetes Technol Ther. 2017 Feb;19(S1):S3-S10.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Medical Focus Journal